Production (Stage)
Generation Bio Co.
GBIO
$0.3719
-$0.0111-2.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 146.47% | 236.92% | 514.08% | 1,397.05% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 146.47% | 236.92% | 514.08% | 1,397.05% | -- |
| Cost of Revenue | -29.50% | -37.91% | -22.03% | -11.61% | -4.86% |
| Gross Profit | 59.15% | 60.75% | 45.12% | 29.02% | 18.58% |
| SG&A Expenses | -23.26% | -23.60% | -8.64% | -5.06% | -4.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.47% | -31.22% | -15.76% | -8.51% | -4.51% |
| Operating Income | 40.32% | 42.64% | 27.65% | 17.59% | 11.59% |
| Income Before Tax | 57.45% | -3.99% | -17.48% | -24.87% | -26.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 57.45% | -3.99% | -17.48% | -24.87% | -26.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.45% | -3.99% | -17.48% | -24.87% | -26.41% |
| EBIT | 40.32% | 42.64% | 27.65% | 17.59% | 11.59% |
| EBITDA | 41.69% | 44.08% | 28.62% | 18.19% | 12.02% |
| EPS Basic | 57.86% | -0.56% | -10.63% | -14.75% | -12.44% |
| Normalized Basic EPS | 42.88% | 47.54% | 34.71% | 27.53% | 25.25% |
| EPS Diluted | 57.86% | -0.56% | -10.63% | -14.75% | -12.44% |
| Normalized Diluted EPS | 42.88% | 47.54% | 34.71% | 27.53% | 25.25% |
| Average Basic Shares Outstanding | 1.14% | 3.35% | 5.80% | 8.51% | 12.05% |
| Average Diluted Shares Outstanding | 1.14% | 3.35% | 5.80% | 8.51% | 12.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |